Literature DB >> 2046641

Maternal substance use and subsequent sudden infant death syndrome (SIDS) in offspring.

S R Kandall1, J Gaines.   

Abstract

Over 400,000 babies may be born annually following intrauterine exposure to opiates, stimulants and other illicit drugs. In addition, fetal exposure to alcohol and nicotine is common: of the 56 million women in the childbearing age range, 34 million are drinkers and 18 million are smokers. Published epidemiologic data suggest a strong association between Sudden Infant Death Syndrome (SIDS) and maternal smoking, a weaker association between SIDS and maternal opiate use, a still weaker association between SIDS and maternal cocaine use, and no association of SIDS and maternal alcohol use. Direct scientific links, however, between SIDS and exposure to any of these substances are still lacking. Because of reports in the medical literature and lay press linking maternal substance use to subsequent SIDS, specific drug-related counseling issues must be recognized by health professionals to provide effective intervention in the event of a SIDS death.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2046641     DOI: 10.1016/0892-0362(91)90016-p

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  10 in total

1.  How early bonding, depression, illicit drug use, and perceived support work together to influence drug-dependent mothers' caregiving.

Authors:  Nancy E Suchman; Thomas J McMahon; Arietta Slade; Suniya S Luthar
Journal:  Am J Orthopsychiatry       Date:  2005-07

2.  Caffeine and alcohol as risk factors for sudden infant death syndrome. Nordic Epidemiological SIDS Study.

Authors:  B Alm; G Wennergren; G Norvenius; R Skjaerven; N Oyen; K Helweg-Larsen; H Lagercrantz; L M Irgens
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

3.  Substance use among women: associations with pregnancy, parenting, and race/ethnicity.

Authors:  Pradip K Muhuri; Joseph C Gfroerer
Journal:  Matern Child Health J       Date:  2008-06-20

4.  Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadone.

Authors:  Nathalie Colombini; Riad Elias; Muriel Busuttil; Myriam Dubuc; Marie-Ange Einaudi; Martine Bues-Charbit
Journal:  Pharm World Sci       Date:  2007-11-16

5.  Respiratory effects of chronic in utero methadone or morphine exposure in the neonatal guinea pig.

Authors:  Rosemary T Nettleton; Michael Wallisch; George D Olsen
Journal:  Neurotoxicol Teratol       Date:  2008-03-21       Impact factor: 3.763

6.  Chronic in utero buprenorphine exposure causes prolonged respiratory effects in the guinea pig neonate.

Authors:  Michael Wallisch; Chinmayee V Subban; Rosemary T Nettleton; George D Olsen
Journal:  Neurotoxicol Teratol       Date:  2009-12-31       Impact factor: 3.763

7.  Development and validation of the Safe Sleep Calculator to assess risk of sudden unexpected death in infancy.

Authors:  C G McIntosh; J M D Thompson; K Leech; R Carpenter; E A Mitchell
Journal:  Sci Rep       Date:  2022-04-12       Impact factor: 4.379

8.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

9.  Maternal nicotinic exposure produces a depressed hypoxic ventilatory response and subsequent death in postnatal rats.

Authors:  Jianguo Zhuang; Lei Zhao; Fadi Xu
Journal:  Physiol Rep       Date:  2014-05-28

10.  Prenatal Opioid Exposure and Intermittent Hypoxemia in Preterm Infants: A Retrospective Assessment.

Authors:  Elie G Abu Jawdeh; Philip M Westgate; Amrita Pant; Audra L Stacy; Divya Mamilla; Aayush Gabrani; Abhijit Patwardhan; Henrietta S Bada; Peter Giannone
Journal:  Front Pediatr       Date:  2017-12-06       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.